Skip to main content

A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates

  • Protocol
  • First Online:
Proteomics for Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1647))

Abstract

The combination of photoaffinity labeling (PAL) and quantitative chemoproteomics enables the comprehensive, unbiased determination of protein interaction profiles to support target identification of bioactive small molecules. This approach is amenable to cells in culture and compatible with pharmacologically relevant transmembrane target classes like G-protein coupled receptors and ions channels which have been notoriously hard to access by conventional chemoproteomics approaches. Here, we describe a strategy that combines PAL probe titration and competition with excess parental compounds with the goal of enabling the identification of specific interactors as well as assessing the functional relevance of a binding event for the phenotype under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10(7):507–519. doi:10.1038/nrd3480

    Article  CAS  PubMed  Google Scholar 

  2. Schirle M, Jenkins JL (2016) Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov Today 21(1):82–89. doi:10.1016/j.drudis.2015.08.001

    Article  CAS  PubMed  Google Scholar 

  3. Rix U, Superti-Furga G (2009) Target profiling of small molecules by chemical proteomics. Nat Chem Biol 5(9):616–624. doi:10.1038/nchembio.216

    Article  CAS  PubMed  Google Scholar 

  4. Bantscheff M, Schirle M, Sweetman G et al (2007) Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 389(4):1017–1031. doi:10.1007/s00216-007-1486-6

    Article  CAS  PubMed  Google Scholar 

  5. Bantscheff M, Lemeer S, Savitski MM, Kuster B (2012) Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal Bioanal Chem 404(4):939–965. doi:10.1007/s00216-012-6203-4

    Article  CAS  PubMed  Google Scholar 

  6. Bassilana F, Carlson A, DaSilva JA et al (2014) Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39. Nat Chem Biol 10(5):343–349. doi:10.1038/nchembio.1481

    Article  CAS  PubMed  Google Scholar 

  7. Mackinnon AL, Taunton J (2009) Target identification by Diazirine photo-cross-linking and click chemistry. Curr Protoc Chem Biol 1:55–73. doi:10.1002/9780470559277.ch090167

    PubMed  PubMed Central  Google Scholar 

  8. Savitski MM, Mathieson T, Zinn N et al (2013) Measuring and managing ratio compression for accurate iTRAQ/TMT quantification. J Proteome Res 12(8):3586–3598. doi:10.1021/pr400098r

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank John Damask and Stephen Marshall for their crucial role in building the data processing and analysis environment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Markus Schirle .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Thomas, J.R., Brittain, S.M., Lipps, J., Llamas, L., Jain, R.K., Schirle, M. (2017). A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates. In: Lazar, I., Kontoyianni, M., Lazar, A. (eds) Proteomics for Drug Discovery. Methods in Molecular Biology, vol 1647. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7201-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7201-2_1

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7200-5

  • Online ISBN: 978-1-4939-7201-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics